Jarvis Lee is preferred know on parp inhibitor exploration. One promising avenue of cancer research is a study of several compounds called bcl-2 inhibitor, gemcitabine. My websites: PARP inhibitor and bcl-2 inhibitor, gemcitabine - Critical Marker Of Reaction to Gemcitabine In Pancreatic Melanoma Identified.